Juncus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-05-2024
- Paid Up Capital ₹ 0.10 M
as on 18-05-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
About Juncus Life Sciences
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Yaduraj Bahadur and Vivek Tiwari serve as directors at the Company.
- CIN/LLPIN
U24297HR2020PTC084639
- Company No.
084639
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Juncus Life Sciences Private Limited offer?
Juncus Life Sciences Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Plant Extracts, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Vitamin Tablets & Capsules, Ayurvedic Herbal Syrups & Tonics, Nutritional Supplements, Ayur.
Who are the key members and board of directors at Juncus Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yaduraj Bahadur  | Director | 08-Jan-2020 | Current |
| Vivek Tiwari | Director | 08-Jan-2020 | Current |
Financial Performance and Corporate Structure Insights of Juncus Life Sciences.
Juncus Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Juncus Life Sciences?
Unlock access to Juncus Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Juncus Life Sciences?
Unlock and access historical data on people associated with Juncus Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Juncus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Juncus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
